Menu
GeneBe

4-41745956-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_003924.4(PHOX2B):c.796G>A(p.Ala266Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00002 in 150,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A266S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 7.7e-7 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PHOX2B
NM_003924.4 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.02
Variant links:
Genes affected
PHOX2B (HGNC:9143): (paired like homeobox 2B) The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM1
In a region_of_interest Disordered (size 30) in uniprot entity PHX2B_HUMAN there are 10 pathogenic changes around while only 4 benign (71%) in NM_003924.4
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.20186713).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PHOX2BNM_003924.4 linkuse as main transcriptc.796G>A p.Ala266Thr missense_variant 3/3 ENST00000226382.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PHOX2BENST00000226382.4 linkuse as main transcriptc.796G>A p.Ala266Thr missense_variant 3/31 NM_003924.4 P1

Frequencies

GnomAD3 genomes
AF:
0.0000200
AC:
3
AN:
150116
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000446
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
7.67e-7
AC:
1
AN:
1303112
Hom.:
0
Cov.:
31
AF XY:
0.00000155
AC XY:
1
AN XY:
643242
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.71e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000200
AC:
3
AN:
150116
Hom.:
0
Cov.:
32
AF XY:
0.0000273
AC XY:
2
AN XY:
73208
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000446
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 18, 2022The p.A266T variant (also known as c.796G>A), located in coding exon 3 of the PHOX2B gene, results from a G to A substitution at nucleotide position 796. The alanine at codon 266 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Uncertain
0.025
T
BayesDel_noAF
Benign
-0.20
Cadd
Benign
22
Dann
Benign
0.97
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.52
D
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
0.91
N
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
0.22
N
REVEL
Benign
0.26
Sift
Benign
0.98
T
Sift4G
Benign
0.89
T
Polyphen
0.84
P
Vest4
0.25
MutPred
0.22
Gain of glycosylation at A266 (P = 7e-04);
MVP
0.90
MPC
1.1
ClinPred
0.22
T
GERP RS
2.9
Varity_R
0.10
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1260084723; hg19: chr4-41747973; COSMIC: COSV56928585; COSMIC: COSV56928585; API